Editorial for "MRI Radiomics-Based Machine Learning for Predict of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions"

被引：3
|
作者：
Nketiah, Gabriel A. [1 ]
Bathen, Tone F. [1 ]
机构：
[1] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway
来源：
JOURNAL OF MAGNETIC RESONANCE IMAGING | 2021年 / 54卷 / 05期
关键词：
DATA SYSTEM; RISK;
D O I：
10.1002/jmri.27752
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1474 / 1475
页数：2
相关论文
共 50 条
  • [21] Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers
    Park, Sung Yoon
    Jung, Dae Chul
    Oh, Young Taik
    Cho, Nam Hoon
    Choi, Young Deuk
    Rha, Koon Ho
    Hong, Sung Joon
    Han, Kyunghwa
    RADIOLOGY, 2016, 280 (01) : 108 - 116
  • [22] Avoiding Unnecessary Systematic Biopsy in Clinically Significant Prostate Cancer: Comparison Between MRI-Based Radiomics Model and PI-RADS Category
    Cheng, Xueqing
    Chen, Yuntian
    Xu, Hui
    Ye, Lei
    Tong, Shun
    Li, Haixia
    Zhang, Tianjing
    Tian, Song
    Qi, Jin
    Zeng, Hao
    Yao, Jin
    Song, Bin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (02) : 578 - 586
  • [23] Negative MRI rules out clinically significant prostate cancer regardless of PI-RADS era
    Shadbahr, T.
    Pylvalainen, J.
    Hoffstrom, J.
    Kenttamies, A.
    Mirtti, T.
    Laajala, T. D.
    Rannikko, A. S.
    EUROPEAN UROLOGY, 2024, 85 : S464 - S466
  • [24] Role of MRI radiomics analysis and Pi-RADS score in prostate cancer
    Angrisani, A.
    D'Alessandro, L.
    Grassi, R.
    Nardone, V.
    D'Ippolito, E.
    Guida, C.
    Reginelli, A.
    Cappabianca, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1201 - S1201
  • [25] Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer?
    Patrick Asbach
    Anwar R. Padhani
    European Radiology, 2023, 33 : 5825 - 5827
  • [26] Are upgraded DCE-positive PI-RADS 3 lesions truly suspicious for clinically significant prostate cancer?
    Asbach, Patrick
    Padhani, Anwar R.
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5825 - 5827
  • [27] Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
    Gaudiano, Caterina
    Braccischi, Lorenzo
    Taninokuchi Tomassoni, Makoto
    Paccapelo, Alexandro
    Bianchi, Lorenzo
    Corcioni, Beniamino
    Ciccarese, Federica
    Schiavina, Riccardo
    Droghetti, Matteo
    Giunchi, Francesca
    Fiorentino, Michelangelo
    Brunocilla, Eugenio
    Golfieri, Rita
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] PI-RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
    Camacho, Andres
    Salah, Fatima
    Bay, Camden P.
    Waring, Jonathan
    Umeton, Renato
    Hirsch, Michelle S.
    Cole, Alexander P.
    Kibel, Adam S.
    Loda, Massimo
    Tempany, Clare M.
    Fennessy, Fiona M.
    BJUI COMPASS, 2023, 4 (04): : 473 - 481
  • [29] Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions
    Valentina Brancato
    Marco Aiello
    Luca Basso
    Serena Monti
    Luigi Palumbo
    Giuseppe Di Costanzo
    Marco Salvatore
    Alfonso Ragozzino
    Carlo Cavaliere
    Scientific Reports, 11
  • [30] Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI-RADS v2.1 Score ≥3
    Ruan, Mingjian
    Liu, Yi
    Yao, Kaifeng
    Wang, Kexin
    Fan, Yu
    Wu, Shiliang
    Wang, Xiaoying
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2024, 60 (05) : 2130 - 2141
12345